Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Malgorzata Solnik"'
Autor:
Kamil J. Synoradzki, Natalia Paduszyńska, Malgorzata Solnik, Mario Damiano Toro, Krzysztof Bilmin, Elżbieta Bylina, Piotr Rutkowski, Yacoub A. Yousef, Claudio Bucolo, Sandrine Anne Zweifel, Michele Reibaldi, Michal Fiedorowicz, Anna M. Czarnecka
Publikováno v:
Current Oncology, Vol 31, Iss 2, Pp 778-800 (2024)
Molecular biology studies of uveal melanoma have resulted in the development of novel immunotherapy approaches including tebentafusp—a T cell–redirecting bispecific fusion protein. More biomarkers are currently being studied. As a result, combine
Externí odkaz:
https://doaj.org/article/960539c0f6e54130a155e5bda2dce710
Autor:
Robert Rejdak, Piotr Merks, Malgorzata Solnik, Kamil Synoradzki, Anna M. Czarnecka, Mateusz Spałek, Mario Damiano Toro, Michal Fiedorowicz, Krzysztof Bilmin, Tamara Kujawska
Publikováno v:
Cancers
Cancers, Vol 14, Iss 134, p 134 (2022)
Cancers, Vol 14, Iss 134, p 134 (2022)
Simple Summary Uveal melanoma is the most common intraocular cancer. The current eye-sparing treatment options include mostly plaque brachytherapy. However, the effectiveness of these methods is still unsatisfactory. In this article, we review severa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8b8d92ee4ed6979eb9a16ec2712b722
http://europepmc.org/articles/PMC8750035
http://europepmc.org/articles/PMC8750035
Autor:
Katarzyna Dyndor, Natalia Paduszynska, Michal Fiedorowicz, Mario Damiano Toro, Robert Rejdak, Malgorzata Solnik, Kamil Synoradzki, Yacoub A. Yousef, Anna M. Czarnecka, Tomasz Choragiewicz
Uveal melanoma is the most common primary intraocular malignancy in adults characterized by insidious onset and poor prognosis strongly associated with tumor size and the presence of distant metastases, most commonly in the liver. Contrary to most tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::876fc63d467e0751eeb2573276fdebd2
https://doi.org/10.20944/preprints202109.0149.v1
https://doi.org/10.20944/preprints202109.0149.v1
Autor:
Synoradzki, Kamil J.1 (AUTHOR) ksynoradzki@imdik.pan.pl, Paduszyńska, Natalia2,3 (AUTHOR) elzbieta.bylina@pib-nio.pl, Solnik, Malgorzata2,3 (AUTHOR) m.solnik98@gmail.com, Toro, Mario Damiano4,5 (AUTHOR) toro.mario@email.it, Bilmin, Krzysztof6 (AUTHOR) kbilmin@wp.pl, Bylina, Elżbieta3,7 (AUTHOR), Rutkowski, Piotr3 (AUTHOR), Yousef, Yacoub A.8 (AUTHOR) yyousef@khcc.jo, Bucolo, Claudio9 (AUTHOR) claudio.bucolo@unict.it, Zweifel, Sandrine Anne10,11 (AUTHOR) sandrine.zweifel@usz.ch, Reibaldi, Michele12 (AUTHOR) michele.reibaldi@unito.it, Fiedorowicz, Michal13 (AUTHOR), Czarnecka, Anna M.3,14 (AUTHOR) anna.czarnecka@gmail.com
Publikováno v:
Current Oncology. Feb2024, Vol. 31 Issue 2, p778-800. 23p.
Publikováno v:
Immunotherapy Weekly; 2/20/2024, p1363-1363, 1p